Want to see IN:TATACHEM full AI Analyst Report?
Tata Chemicals Limited (TATACHEM) Ratios
Tata Chemicals Limited Ratios
IN:TATACHEM's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:TATACHEM's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.07 | 1.09 | 1.05 | 1.66 | 1.23 |
| Quick Ratio | 0.61 | 0.68 | 0.63 | 1.15 | 0.91 |
| Cash Ratio | 0.06 | 0.09 | 0.07 | 0.10 | 0.11 |
| Solvency Ratio | -0.04 | 0.08 | 0.08 | 0.22 | 0.14 |
| Operating Cash Flow Ratio | 0.15 | 0.29 | 0.50 | 0.61 | 0.23 |
| Short-Term Operating Cash Flow Coverage | 0.42 | 0.82 | 1.39 | 5.47 | 0.53 |
| Net Current Asset Value | $ -96.50B | $ -85.59B | $ -72.75B | $ -62.78B | $ -59.41B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.20 | 0.19 | 0.15 | 0.18 | 0.21 |
| Debt-to-Equity Ratio | 0.38 | 0.33 | 0.25 | 0.32 | 0.38 |
| Debt-to-Capital Ratio | 0.27 | 0.25 | 0.20 | 0.24 | 0.28 |
| Long-Term Debt-to-Capital Ratio | 0.18 | 0.16 | 0.12 | 0.22 | 0.17 |
| Financial Leverage Ratio | 1.84 | 1.75 | 1.65 | 1.78 | 1.85 |
| Debt Service Coverage Ratio | 0.02 | 0.64 | 0.94 | 3.81 | 0.63 |
| Interest Coverage Ratio | 1.02 | 8.53 | 11.67 | 14.43 | 17.33 |
| Debt to Market Cap | 0.48 | 0.29 | 0.18 | 0.25 | 0.27 |
| Interest Debt Per Share | 337.21 | 296.20 | 235.25 | 263.08 | 284.66 |
| Net Debt to EBITDA | 22.90 | 3.54 | 1.83 | 1.48 | 2.67 |
| Profitability Margins | |||||
| Gross Profit Margin | 43.47% | 60.07% | 60.40% | 59.12% | 58.83% |
| EBIT Margin | -5.96% | 5.84% | 12.69% | 17.97% | 12.27% |
| EBITDA Margin | 2.28% | 12.37% | 18.23% | 23.26% | 18.62% |
| Operating Profit Margin | 4.14% | 27.14% | 32.55% | 34.90% | 31.20% |
| Pretax Profit Margin | -10.00% | 3.50% | 5.38% | 16.32% | 13.21% |
| Net Profit Margin | -13.00% | 1.58% | 1.74% | 13.80% | 9.97% |
| Continuous Operations Profit Margin | -11.76% | 2.38% | 2.91% | 14.60% | 11.09% |
| Net Income Per EBT | 129.95% | 45.11% | 32.29% | 84.56% | 75.46% |
| EBT Per EBIT | -241.56% | 12.89% | 16.53% | 46.77% | 42.33% |
| Return on Assets (ROA) | -4.86% | 0.62% | 0.73% | 6.60% | 3.72% |
| Return on Equity (ROE) | -8.94% | 1.09% | 1.20% | 11.75% | 6.89% |
| Return on Capital Employed (ROCE) | 1.87% | 12.77% | 16.35% | 19.41% | 14.72% |
| Return on Invested Capital (ROIC) | 1.73% | 8.10% | 8.24% | 17.02% | 11.06% |
| Return on Tangible Assets | -6.50% | 0.87% | 1.02% | 9.44% | 5.25% |
| Earnings Yield | -12.76% | 1.10% | 0.97% | 9.35% | 5.07% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.91 | 7.84 | 6.99 | 5.18 | 5.31 |
| Payables Turnover | 3.23 | 2.37 | 2.58 | 2.64 | 2.13 |
| Inventory Turnover | 2.67 | 2.32 | 2.42 | 2.71 | 2.27 |
| Fixed Asset Turnover | 1.24 | 1.39 | 1.64 | 1.88 | 1.60 |
| Asset Turnover | 0.37 | 0.39 | 0.42 | 0.48 | 0.37 |
| Working Capital Turnover Ratio | 27.94 | 33.34 | 8.63 | 6.84 | 6.59 |
| Cash Conversion Cycle | 85.21 | 49.53 | 61.48 | 67.05 | 58.06 |
| Days of Sales Outstanding | 61.74 | 46.58 | 52.21 | 70.50 | 68.70 |
| Days of Inventory Outstanding | 136.45 | 157.05 | 150.88 | 134.64 | 161.08 |
| Days of Payables Outstanding | 112.99 | 154.10 | 141.61 | 138.10 | 171.72 |
| Operating Cycle | 198.20 | 203.64 | 203.09 | 205.15 | 229.78 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 40.78 | 69.12 | 118.39 | 116.62 | 64.55 |
| Free Cash Flow Per Share | -6.52 | -9.58 | 46.40 | 54.68 | 14.43 |
| Dividend Paid and CapEx Coverage Ratio | 0.70 | 0.74 | 1.32 | 1.57 | 1.07 |
| Capital Expenditure Coverage Ratio | 0.86 | 0.88 | 1.64 | 1.88 | 1.29 |
| Operating Cash Flow Coverage Ratio | 0.13 | 0.25 | 0.54 | 0.47 | 0.23 |
| Operating Cash Flow to Sales Ratio | 0.07 | 0.12 | 0.20 | 0.18 | 0.13 |
| Free Cash Flow Yield | -1.12% | -1.14% | 4.27% | 5.62% | 1.48% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -7.84 | 105.90 | 103.35 | 10.69 | 19.73 |
| Price-to-Sales (P/S) Ratio | 1.02 | 1.44 | 1.80 | 1.48 | 1.97 |
| Price-to-Book (P/B) Ratio | 0.70 | 0.99 | 1.25 | 1.26 | 1.36 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -89.51 | -87.68 | 23.43 | 17.78 | 67.54 |
| Price-to-Operating Cash Flow Ratio | 14.30 | 12.15 | 9.18 | 8.34 | 15.10 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | -3.73 | -1.18 | 0.12 | 0.05 |
| Enterprise Value Multiple | 67.66 | 15.16 | 11.68 | 7.83 | 13.23 |
| Enterprise Value | 224.62B | 279.17B | 328.35B | 305.62B | 310.85B |
| EV to EBITDA | 67.66 | 15.16 | 11.68 | 7.83 | 13.23 |
| EV to Sales | 1.54 | 1.88 | 2.13 | 1.82 | 2.46 |
| EV to Free Cash Flow | -135.32 | -114.41 | 27.78 | 21.94 | 84.58 |
| EV to Operating Cash Flow | 21.62 | 15.85 | 10.89 | 10.29 | 18.90 |
| Tangible Book Value Per Share | 483.26 | 459.69 | 491.26 | 396.93 | 364.64 |
| Shareholders’ Equity Per Share | 832.36 | 847.63 | 873.04 | 774.11 | 716.49 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.18 | 0.32 | 0.46 | 0.11 | 0.16 |
| Revenue Per Share | 572.44 | 584.36 | 605.33 | 659.02 | 495.45 |
| Net Income Per Share | -74.42 | 9.22 | 10.52 | 90.95 | 49.38 |
| Tax Burden | 1.30 | 0.45 | 0.32 | 0.85 | 0.75 |
| Interest Burden | 1.68 | 0.60 | 0.42 | 0.91 | 1.08 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.39 | 0.33 | 0.12 | 0.10 | 0.13 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.55 | 3.10 | 3.70 | 1.09 | 0.98 |
Currency in INR